U.S. market Closed. Opens in 11 hours 32 minutes

ARNA | Arena Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
Revenue54.00K319.00K806.43M17.97M21.34M123.97M38.33M36.97M81.39M27.59M12.72M16.61M10.39M9.81M19.33M30.57M23.23M13.69M12.83M19.42M18.06M7.68M1.00N/A
Cost of RevenueN/AN/AN/AN/AN/A15.34M13.18M7.76M6.18M3.67M8.10M7.41M6.54M8.52MN/AN/AN/AN/AN/AN/AN/A-787.83K-399.28KN/A
Gross Profit54.00K319.00K806.43M17.97M21.34M108.63M25.15M29.21M75.21M23.92M4.62M9.20M3.85M1.29MN/A30.57M23.23MN/A12.83MN/AN/A8.47M399.28KN/A
Operating Expenses554.35M426.94M323.67M162.73M101.29M97.62M124.41M134.45M98.17M81.00M83.95M105.55M138.91M237.22M177.63M123.39M94.37M71.47M64.30M55.75M33.78M19.89M10.93MN/A
Selling, General & Admin126.20M103.20M77.60M47.70M30.30M31.20M36.00M34.10M31.70M26.20M24.25M27.94M25.25M30.54M26.57M18.47M12.88M10.45M8.55M7.50M5.39M2.68M1.81M728.81K
Research & Development419.51M323.74M231.50M115.03M70.99M66.42M88.41M100.35M66.47M54.11M58.71M75.46M110.16M204.37M149.52M103.39M79.51M57.73M50.89M44.40M22.86M12.08M8.34M2.62M
Other Operating Expenses8.64MN/A14.57MN/AN/AN/AN/AN/AN/A691.00K997.00K2.16M3.51M2.31M1.54M1.54M1.98M3.29M4.86M3.85M5.52M5.13M777.39KN/A
Operating Income-612.27M-426.64M482.75M-144.78M-91.97M11.01M-99.26M-105.24M-22.95M-57.09M-79.33M-96.36M-135.06M-235.93M-158.30M-92.82M-71.14M-57.78M-51.46M-36.33M-15.72M-11.42M-10.53M-3.34M
Other Expenses / Income-4.16M21.91M25.14M5.95M-3.85M-33.86M-8.75M44.77M3.50M-28.36M-15.70M-6.97M-112.00K-3.34M30.00K-4.28M647.11K191.42K1.98M-817.04K1.54M632.73K9.42KN/A
Before Tax Income-616.43M-404.73M507.89M-138.83M-95.81M-22.85M-108.01M-60.47M-19.45M-85.45MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses4.16M26.43M110.33M-110.27M2.27MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-620.59M-404.73M397.56M-29.40M-91.41M-22.52M-107.98M-60.51M-19.43M-85.48M-109.22M-124.53M-153.20M-237.57M-143.17M-86.25M-67.90M-57.99M-47.06M-32.83M-6.88M-6.36M-10.24M-3.40M
Interest Expenses4.16M4.52M4.79M5.70M6.12M6.51M6.83M6.92M7.09M9.12M14.31M21.68M18.72MN/AN/A1.84M1.84MN/A37.23KN/AN/A220.48KN/AN/A
Basic Shares Outstanding54.77M54.77M51.70M47.04M32.99M24.31M24.07M21.97M21.81M19.65M13.92M10.96M8.43M7.38M6.28M4.68M3.44M2.55M2.72M2.75M2.50M1.01M792.70K96.68K
Diluted Shares Outstanding54.77M54.77M51.70M47.04M32.99M24.31M24.07M21.97M21.81M19.65M13.92M10.96M8.43M7.38M6.28M4.68M3.44M2.55M2.72M2.75M2.50M1.01M792.70K96.68K
EBITDA-608.40M-396.35M515.91M-130.21M-81.01M-6.65M-91.11M-44.43M-4.14M-66.61M-83.79M-90.30M-119.96M-222.93M-134.24M-76.23M-57.08M-46.30M-34.75M-24.05M319.80K-1.01M-9.46M-3.34M
EBITDA Margin-1,126,670.37%-124,248.59%63.97%-724.60%-379.67%-5.36%-237.72%-120.18%-5.09%-241.46%-658.79%-543.56%-1,154.91%-2,272.69%-694.37%-249.37%-245.70%-338.31%-270.78%-123.82%1.77%-13.16%-946,056,300.00%0.00%
EBIT-612.27M-373.78M512.68M-133.97M-83.02M-16.00M-101.15M-53.59M-12.34M-76.36M-94.92M-102.85M-134.49M-237.57M-143.17M-84.41M-66.06M-57.99M-47.02M-32.83M-6.88M-6.14M-10.24M-3.40M
EBIT Margin-1,133,840.74%-117,173.35%63.57%-745.51%-389.07%-12.91%-263.92%-144.96%-15.17%-276.79%-746.25%-619.11%-1,294.75%-2,421.99%-740.56%-276.13%-284.34%-423.74%-366.38%-169.04%-38.11%-79.93%-1,023,795,000.00%0.00%
Financial Year End2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙